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From the Editor 
 
Uncle Sam's Debut on the Value-Based Purchasing Stage 
 
In the fall of 2006, Secretary Michael Leavitt of the US Department of 
Health and Human Services announced with great fanfare that Uncle 
Sam was going to become a value-based purchaser of health benefits.  
An article in this issue of VBP highlights how the Centers for Medicare 
and Medicaid Services (CMS) has begun to implement this vision in 
the Medicare program, starting with an emphasis on hospital inpatient 
services, but branching out to affect all health care services, including 
physician services.  Now that the “600 pound gorilla” has entered the 
game, many employers, and indeed some Benefits College alumni, 
may be wondering what this means for your own benefits purchasing 
strategy. 
 
In answering that question, I’m reminded of how I first ended up 
partnering with Jerry Burgess and Andy Webber in the development of 
the College for Advanced Management of Health Benefits.  Our 
Jefferson Department of Health Policy was engaged in research, 
supported by the Commonwealth Fund, examining whether the “value 
based purchasing movement had legs,” i.e. did employers really care 
about quality?  Our initial findings, published in a Fund report, included 
the important assessment that employers were starting to care about 
quality and value, and that they played a pivotal role in shaping policy.  
Government might have the economic and political power to influence 
the market, but it would not exercise that power in the absence of 
proven interventions.  The employer-led value-based purchasing 
movement was, and remains, an essential driver in developing, testing, 
and disseminating quality and value-improving interventions that 
government can then adapt and implement on a national scale. 
 
As CMS moves forward with its VBP initiatives, the employer and 
coalition imperative to work at the local level remains strong.  Work is 
still needed to answer a myriad of important questions not readily 
approachable by the “big G”, for example:  
 
• How can quality and value data be used to drive appropriate care-
seeking by consumers? 
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• How can the principles of “value-based   
benefit design” move beyond modifying 
drug co-payments to a broader range of 
value-linked benefit offerings? 
 
• To what extent is the current wellness 
fad going to translate into true health 
improvement and cost-savings? 
 
• How can employers work in partnership 
with providers and other community 
members to best promote value? 
  
The list of important questions is clearly much 
broader and deeper.  Government plays an 
important role in dissemination, but employers 
remain the central agents in figuring out what 
works (and what doesn’t) – and sharing those 
experiences through publication, presentation 
at conferences, and networking with 
colleagues and coalitions.  I hope that you will 
read this issue of Value Based Purchasing, 
and then get back to the important work at 
hand. 
 
Neil Goldfarb, Editor 
Value-Based Purchasing 
 
 
The Centers for Medicare and 
Medicaid Services’ 
Approach to Value-Based Purchasing 
 
Bettina Berman, RN 
 
 
Although evidence suggests that both the 
quality and the affordability of health care can 
be improved1, it is likely that such 
improvements will come at great cost.  
Healthcare expenditures in the United States 
(U.S.) are expected to rise precipitously - from 
$1.5 trillion in 2005 to over $4 trillion in 2016. 2 
Medicare, the nation’s single largest health 
care purchaser, spent an estimated $425 
billion on health services in 2007. With the 
projected growth in Medicare beneficiaries, the 
amount may surpass $800 billion by 2017, 
placing the government under significant 
pressure to control health care costs. 3     
 
This article is intended as a brief summary of 
the Centers for Medicare and Medicaid 
Services’ (CMS) experience and its 
prospective strategies for health care quality 
improvement, including relevant legislation and 
potential future trends for value-based 
programs under CMS. 
 
Initially, the Medicare payment system was 
based on provider claims for “customary, 
reasonable, and necessary costs.” In the 
1980’s, Medicare introduced a prospective 
payment system for hospitals based on 
Diagnosis-Related Groups (DRG), but 
maintained a fee-for-service payment for 
ambulatory services. This payment system 
rewards providers for volume of services rather 
than the quality of those services, and 
encourages high resource consumption rather 
than efficient health care delivery. An 
increasing body of evidence 2 has revealed 
wide variations in quality and costs for the 
health care services provided to Medicare 
beneficiaries.  
 
Armed with this knowledge, CMS developed a 
“Roadmap for Quality,” aimed at “transforming 
Medicare from a passive payer to an active 
purchaser of high quality efficient care.”4 In an 
effort to take a leadership role in transforming 
the health care system by supporting the 
Institute of Medicine’s (IOM) 6 aims for health 
care (ie, Safe, Effective, Patient-centered, 
Timely, Efficient, and Equitable), CMS adopted 
the following strategies for achieving high 
quality, patient centered care: 
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1. Work through partnerships  
2. Publish quality measurement and 
information 
3. Pay in a way that expresses a 
commitment to quality and rewards 
rather than inadvertently punishing 
providers and practitioners for doing the 
right thing 
4. Promote health information technology 
5. Become an active partner in creating 
and using information about the 
effectiveness of healthcare technologies 
  
The Deficit Reduction Act of 2005 (DRA) 
required a quality adjustment in Medicare 
Diagnosis Related Group (DRG) payment for 
certain hospital-acquired conditions (HAC), 
including serious preventable events, pressure 
ulcers, falls, and vascular catheter-associated 
infections. The legislation also authorized the 
development of a plan for a hospital value-
based program to commence in FY 2009. CMS 
has received support for the value-based plan 
from multiple stakeholders, including private 
insurers, the National Quality Forum (NQF), 
and the Medicare Payment Advisory 
Commission (MedPAC).  
 
In its report, “Rewarding Provider 
Performance”5, the IOM recommended that 
“the Secretary of the Department of Health and 
Human Services (DHHS) should implement 
pay for performance in Medicare using a 
phased approach as a stimulus to foster 
comprehensive and system wide 
improvements in the quality of health care.”  
The report recommended transparency and 
incentive measures, stating that such 
measures will likely improve health care 
quality, but not necessarily reduce costs. 
 
The final plan for a hospital payment system 
based on value was presented to the Congress 
in November of 2007. 6 The plan proposes a 
value-based program which will eventually 
phase out Medicare’s current Reporting of 
Hospital Quality Data for Annual Payment 
Update Program (RHQDAPU). Under the new 
program, up to 5 percent of hospital payments 
would be made on the basis of a total 
performance score derived from measures that 
evaluate both clinical care and patient 
satisfaction. 
 
In December of 2006, President Bush signed 
the Tax Relief and Health Care Act (TRHCA), 
paving the way for the Physician Quality 
Reporting Initiative (PQRI), a voluntary pay-for-
reporting system aimed at individual physician 
and non-physician providers of Medicare 
services. The 2007 PQRI program, consisting 
of 74 measures, went into effect on July 1, 
2007. For 2008, the PQRI incorporates 119 
measures of clinical care, resource utilization, 
and structural measures (eg, electronic health 
records). Quality codes (CPT-II codes) are 
linked to the diagnostic codes (CPT-I and/or 
ICD-9) and submitted through the claims 
system. In order to qualify for a bonus of up to 
1.5% of the total allowed charges for Medicare 
services, providers must reach a reporting 
compliance of 80%. Bonus payments and 
feedback reports from CMS, including reporting 
and performance rates, are expected by mid-
2008. 
According to CMS, the future of Medicare 
reimbursement for all payment systems is 
value-based purchasing .7 Future development 
of value-based purchasing programs for 
hospitals includes an emphasis on 
development of efficiency measures. For 
physicians, CMS is currently exploring the 
feasibility of providing resource utilization 
reports for individual providers. Another area 
being investigated by CMS is an “episode of 
care” payment system that offers an incentive 
to physicians who provide both well-
coordinated and cost-effective care8 for 
individual Medicare beneficiaries.   
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Bettina Berman, RN is the Project Director for 
Quality Improvement in the Department of 
Health Policy at Jefferson Medical College.  
She can be reached at: 
Bettina.Berman@jefferson.edu.  
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The Emerging Role of Electronic 
Medical Records-  
What Do They Mean to Quality and 
Value? 
  
Richard Jacoby, MD 
 
 
President Bush identified electronic medical 
records (EMRs), also known as electronic 
health records (EHRs), as one of the 4 
cornerstones in his value driven health care 
initiative.1  EMRs represent a “disruptive 
technology” insofar as they change the way we 
capture, store, retrieve, share, and use health 
information.  Because they have the ability to 
transform and enhance virtually all 
communications, transactions, and analyses 
involving healthcare information, 
implementation of EMRs will have a profound 
effect on patients, providers, and payers. The 
transformation likely will parallel the one which 
occurred as information technology enhanced 
knowledge and productivity in the non-
healthcare segments of the U.S. economy. As 
such, the potential of EMRs to have a 
significant and positive impact on quality and 
value in healthcare is great.  
 
That being said, it is well known that the 
information generated by a system is only as 
good as the data entered into it (ie, “garbage 
in-garbage out”). Whether captured in 
electronic format or on paper, much of the 
information contained in medical records that 
relates to quality and value is entered by 
physicians. For a physician to enter 
“appropriate” information, he or she must be 
aware of the type of information being sought. 
After all, it is the knowledge base and thought 
processes of physicians that interact to result 
in the decisions and behaviors that are 
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documented in a medical record. If physicians 
lack the knowledge or education in quality 
metrics, the concept of value in healthcare, and 
the mechanics of EMR use, they are unlikely to 
capture the required data.  
 
In what now is a classic paper on the quality of 
healthcare delivered to patients in the United 
States, researchers at the Rand Corporation 
found that recommended care that adhered to 
widely agreed upon evidence-based guidelines 
was delivered just 54.9% of the time.2 
Logically, if nothing were to change other than 
records being kept electronically instead of on 
paper, and such a study of quality were 
repeated, there is no reason to assume that 
quality performance would improve. A major 
study recently published in the Archives of 
Internal Medicine supported this premise.  The 
study comparing quality measures pre and 
post EMR implementation showed no 
difference in 14 measures, improvement in 2 
measures, and worse performance on 1 
measure.3  It is with caution then that we 
proceed further with this discussion of the role 
of EMRs and what they mean to quality and 
value.  
What is an EMR?  
Currently, there is no standard definition. In 
simple and practical terms however, whether 
used in the hospital (inpatient) or ambulatory 
(outpatient) setting, an EMR is a medical 
record that has been captured in a digital 
format. It may include data relating to patient 
demographics, medical history, physical 
examination and progress reports of health and 
illnesses, medication and allergy lists, 
immunization status, laboratory test results, 
radiology images, clinical photographs, a 
record of appointments and other reminders, 
 
 
 
billing records, advanced directives, living wills, 
and health powers of attorney.  
Some important “value added” features of 
EMRs (i.e., unavailable in paper based 
records) include: 
• Computerized provider order entry systems 
(CPOE), which include computerized orders 
for prescriptions (“e-prescribing”), 
• Computerized reporting of test results,  
• Clinical decision support systems, which 
may facilitate medical decision-making and 
provide evidence-based recommendations 
for specific medical conditions, and  
• Computer generated prompts and 
reminders.  
In my opinion, these additional features hold 
the key to unlocking the capabilities of EMRs to 
improve quality and value in the American 
healthcare system through their ability to help 
change and augment physician decision 
making. 
What will it take for EMRs to impact quality 
and value on a national scale?  
First, EMRs must become more widely utilized. 
In the most comprehensive study to date that 
reliably measures the state of EMR use by 
doctors and hospitals, researchers from 
Massachusetts General Hospital (MGH) and 
George Washington University (GWU) 
estimate that 1 in 4 doctors (24.9 percent) use 
EMRs to improve how they deliver care to 
patients.  However, less than 1 in 10 are using 
what experts define as a "fully operational" 
system that collects patient information, 
displays test results, allows providers to enter 
medical orders and prescriptions, and helps 
doctors make treatment decisions.4  The same 
study found that “hospital adoption trends are 
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unknown.  Assertions to the contrary, there are 
not enough high-quality, reliable surveys of 
hospital use of EHRs. The research team 
reliably estimates, however, that about 5 
percent of America's 6,000 hospitals have 
adopted computerized physician order entry 
(CPOE) systems, a component of EHRs, to 
help reduce medical errors and ease care 
delivery.”5   
I don’t think EMRs will impact quality and value 
on a national scale until a critical mass of 
physicians is using “fully operational” systems. 
In Donabedian parlance, once the “structure” is 
in place, physicians can and need to be 
educated on the “processes” of quality and 
value which can result in the desired 
“outcomes” of enhanced quality and value. 
To achieve these outcomes, everyone involved 
with EMR implementation must appreciate that 
“implementation of health information 
technology (health IT) is one-third technology 
and two-thirds organizational culture and work 
process.” 6  Physicians and the whole care 
team must embrace this process if the potential 
of EMRs to enhance quality and value in 
healthcare is to be realized.  
 
Dr. Jacoby is Project Director and Clinical 
Associate Professor in the Department of 
Health Policy at Jefferson Medical College.  He 
can be reached at: 
richard.jacoby@jefferson.edu.  
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Challenges and Benefits in Using 
Productivity Data from  
Clinical Trials for VBP Decisions 
  
Thomas J. Bunz, PharmD and  
Laura T. Pizzi, PharmD, MPH 
 
 
Making value based purchasing decisions in 
healthcare requires balancing data from 
several sources.  Information on effectiveness 
of interventions often comes from clinical trials, 
with less reliance on observational studies.  
Historically, the opposite has been true of 
information on the cost of interventions.  More 
recently, providers of healthcare interventions 
such as drugs, devices, and disease 
management programs have begun to 
understand and appreciate the importance of 
costs in healthcare decision making.  Because 
of this, the clinical trials used to demonstrate 
effectiveness have begun to gather data on 
costs.  This article describes some benefits 
and detriments of collecting cost data as a 
component of clinical trials, focusing 
specifically on the data related to productivity.  
 
Studies evaluating the cost of an intervention 
can look at a variety of different types of costs 
depending on the perspective of the study.  For 
  
 
 
Value-Based Purchasing Newsletter 7 March 2008, Volume 2 Issue 2. 
 
 
 
an organization whose sole function is to pay 
for healthcare (e.g., Pharmacy Benefits 
Managers), the direct costs (e.g., the price of a 
pharmaceutical) are the only ones with 
importance.  For employers, it is essential to 
consider the indirect costs and, in particular, 
productivity. 
 
Productivity can be measured in a variety of 
ways, but it is usually reported as an amount of 
productivity lost due to a certain disease, or the 
amount of productivity loss avoided by using a 
specific type of intervention.  Productivity loss 
due to medical conditions can present itself in 
2 ways.  The first is absenteeism, often 
measured by means of reviewing employee 
records of sick days or disability leave.   
 
The second type of productivity loss - 
presenteeism - is more difficult to measure.  
Presenteeism is defined as an employee being 
present at the work place but unable to perform 
at his or her usual level of productivity.  This 
type of productivity loss is often measured by 
surveying employees with certain conditions.  
The employees are asked to report the percent 
of time they have lost from work as a result of 
their condition. 
 
The value of lost productivity can be calculated 
through either the friction cost approach, or the 
human capital approach.  The human capital 
approach yields estimates of wages lost for the 
time that an employee was not working.  The 
friction cost approach adds to that the cost of 
recruiting and training additional labor to 
replace that which was lost.  Depending on the 
condition and the characteristics of the work 
environment, either of these approaches may 
be appropriate. 
 
Using clinical trials to measure changes in 
productivity due to a medical intervention has a 
number of benefits.  These trials are viewed as 
the gold standard for understanding the impact 
of medical interventions on health because 
they control for a lot of potentially confounding 
issues.  In these trials, patients are carefully 
controlled on one or more specific 
interventions, and the outcomes are measured 
prospectively.  This allows researchers to 
arrive at strong conclusions about the causes 
and effects observed in the trial. 
 
There are also some limitations when using 
clinical trials to measures productivity changes 
due to medical interventions.  First, one must 
recognize that health is only one of many 
factors that contribute to work productivity.  
Changes observed during a clinical trial may 
not be due entirely to the intervention being 
tested.  In addition, some individuals choose 
their jobs, at least in part, in order to mitigate 
the limitations of that condition.  For example, a 
retail worker with back pain may choose to look 
for a job at a pharmacy rather than a home 
improvement store in order to lessen the 
likelihood of heavy lifting as a job requirement.  
This type of decision lessens the perceived 
impact of a medical intervention on productivity 
from a clinical trial point of view. 
 
Interpreting studies that evaluate the impact of 
medical interventions on productivity can be 
difficult, but it is an essential step in 
understanding the effect of purchasing 
decisions on employees.  For instance, it is 
important to understand how the conditions in 
which the study was conducted differ from 
those at the company purchasing the medical 
intervention.  The type of work being done as 
well as the demographic characteristics of the 
workers may influence the estimation of wages 
for those workers. 
 
Although it has been demonstrated that 
productivity loss is one of the largest disease-
associated costs for employers, we are still in 
the early stages of measuring productivity 
gains due to specific interventions.  As this 
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important information becomes more available, 
employers should recognize its value in making 
purchasing decisions.  It is equally important 
that the consumers of this information 
understand the benefits and detriments of 
these study designs. 
 
Thomas J. Bunz, PharmD is a Research 
Instructor in the Department of Health Policy at 
Jefferson Medical College.  He can be reached 
at: thomas.bunz@jefferson.edu 
 
Laura T. Pizzi, PharmD, MPH is a Division 
Director and Associate Professor in the 
Department of Health Policy at Jefferson 
Medical College.  She can be reached at: 
laura.pizzi@jefferson.edu 
 
 
 
From the Alumni Network 
 
 
Missy Jarrott, Director of Human Resources for 
Chatham Steel Corporation writes: 
 
 “Do you know of any employers who offer 
wellness programs that hold the employee and 
the spouse accountable for reaching a certain 
level of optimum health by means of lower 
premiums, specific plan designs, etc.?  We 
currently hold our employees accountable; 
however, we hope to reach spouses in 2009.  
Any suggestions?” 
 
Feel free to write to Missy directly at 
Missy_Jarrott@chathamsteel.com.  We also 
would be happy to post your responses in the 
next issue of VBP, so please copy 
neil.goldfarb@jefferson.edu. 
 
 
 
 
 
Benefits College  
Program Schedule for 2008 
 
 
The College for Advanced Management of 
Health Benefits will be hosting 3 course 
sessions in 2008.  By the time you read this, 
the first session, in Nashville, Tennessee, 
hosted by the HealthCare21 Business 
Coalition, will have just been held.  The two 
additional sessions for the year are: 
 
• June 2-5, 2008, in Orlando, Florida, 
hosted by the Florida Health Care 
Coalition 
 
• September 15-18, 2008 in Arlington, 
Virginia (just outside of Washington 
DC), hosted by the Virginia Business 
Coalition on Health and the Mid-Atlantic 
Business Group on Health. 
 
As always, the programs are open to all 
interested direct purchasers of health benefits, 
and those who act as agents on their behalf 
(e.g. brokers and benefit consultants).   For 
more information, visit 
http://www.hc21.org/CAMHB/college_index.ht
m, or contact neil.goldfarb@jefferson.edu. 
 
 
 
